Exponent - Public Comps and Valuation Multiples

Exponent Overview

About Exponent

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

Founded

1989

HQ

Employees

1.2K+

Website

exponent.com

Sectors

Construction & Engineering

Financials

LTM Revenue $523M

LTM EBITDA $162M

EV

$3.9B

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Exponent Financials

Exponent has a last 12-month revenue of $523M and a last 12-month EBITDA of $162M.

In the most recent fiscal year, Exponent achieved revenue of $559M and an EBITDA of $129M.

Exponent expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Exponent valuation multiples based on analyst estimates

Exponent P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$537M	$559M	XXX	XXX	XXX
Gross Profit	n/a	n/a	XXX	XXX	XXX
Gross Margin	NaN%	NaN%	XXX	XXX	XXX
EBITDA	$120M	$129M	XXX	XXX	XXX
EBITDA Margin	22%	23%	XXX	XXX	XXX
Net Profit	$102M	$100M	XXX	XXX	XXX
Net Margin	19%	18%	XXX	XXX	XXX
Net Debt	n/a	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Exponent Stock Performance

As of April 15, 2025, Exponent's stock price is $81.

Exponent has current market cap of $4.1B, and EV of $3.9B.

See Exponent trading valuation data

Exponent Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$3.9B	$4.1B	XXX	XXX	XXX	XXX	$2.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Exponent Valuation Multiples

As of April 15, 2025, Exponent has market cap of $4.1B and EV of $3.9B.

Exponent's trades at 7.5x LTM EV/Revenue multiple, and 24.4x LTM EBITDA.

Analysts estimate Exponent's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for Exponent and 10K+ public comps

Exponent Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$3.9B	XXX	XXX	XXX
EV/Revenue	7.1x	XXX	XXX	XXX
EV/EBITDA	30.5x	XXX	XXX	XXX
P/E	37.8x	XXX	XXX	XXX
P/E/Growth	45.3x	XXX	XXX	XXX
EV/FCF	28.6x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Exponent Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Exponent Valuation Multiples

Exponent's NTM/LTM revenue growth is 4%

Exponent's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.4M for the same period.

Over next 12 months, Exponent's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate Exponent's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for Exponent and other 10K+ public comps

Exponent Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	4%	XXX	XXX	XXX	XXX
EBITDA Margin	23%	XXX	XXX	XXX	XXX
EBITDA Growth	7%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	27%	XXX	XXX	XXX	XXX
Revenue per Employee	$0.5M	XXX	XXX	XXX	XXX
Opex per Employee	$0.4M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	63%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	79%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry